First Ascent Biomedical has appointed Dr. Gilberto Lopes as the Chairman of its Medical Advisory Board, enhancing leadership in Functional Precision Oncology.

Explore how Functional Precision Oncology bridges the gap left by genomic testing in cancer care, empowering oncologists with decisive insights.

First Ascent Biomedical showcases how innovative treatments and resilience transformed young Logan's battle with cancer, offering hope for patients everywhere.

Discover how First Ascent Biomedical is changing cancer treatment by providing personalized insights through innovative AI technology, improving patient outcomes significantly.

First Ascent Biomedical is pioneering cancer treatment through its advanced platform that enhances therapy selection, achieving an impressive 83% patient benefit rate.